dc.contributor.author |
Detsi, A |
en |
dc.contributor.author |
Gavrielatos, E |
en |
dc.contributor.author |
Adam, M-A |
en |
dc.contributor.author |
Igglessi-Markopoulou, O |
en |
dc.contributor.author |
Markopoulos, J |
en |
dc.contributor.author |
Theologitis, M |
en |
dc.contributor.author |
Reis, H |
en |
dc.contributor.author |
Papadopoulos, M |
en |
dc.date.accessioned |
2014-03-01T01:17:13Z |
|
dc.date.available |
2014-03-01T01:17:13Z |
|
dc.date.issued |
2001 |
en |
dc.identifier.issn |
1434193X |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/14393 |
|
dc.subject |
γ-Amino-α-cyano-β-hydroxybutenoates |
en |
dc.subject |
C-Acylation reactions |
en |
dc.subject |
Tautomeric studies |
en |
dc.subject.other |
alpha amino acid |
en |
dc.subject.other |
ethyl 4 [(tert butoxycarbonyl)methylamino] 2 cyano 3 hydroxy 2 butenoate |
en |
dc.subject.other |
gamma amino alpha cyano beta hydroxybutenoate derivative |
en |
dc.subject.other |
methyl 4 [(tert butoxycarbonyl)methylamino] 2 cyano 3 hydroxy 2 butenoate |
en |
dc.subject.other |
unclassified drug |
en |
dc.subject.other |
urethan derivative |
en |
dc.subject.other |
article |
en |
dc.subject.other |
chemical reaction |
en |
dc.subject.other |
drug structure |
en |
dc.subject.other |
drug synthesis |
en |
dc.subject.other |
molecular stability |
en |
dc.subject.other |
nuclear magnetic resonance spectroscopy |
en |
dc.subject.other |
structure analysis |
en |
dc.subject.other |
X ray crystallography |
en |
dc.title |
Synthesis of N-urethane-protected γ-amino-functionalized butenoates and tautomeric studies by means of NMR, X-ray crystallography and ab initio calculations |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1002/1099-0690(200111)2001:22<4337::AID-EJOC4337>3.0.CO;2-S |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1002/1099-0690(200111)2001:22<4337::AID-EJOC4337>3.0.CO;2-S |
en |
heal.publicationDate |
2001 |
en |
heal.abstract |
N-Urethane-protected γ-amino-α-cyano-β-hydroxybutenoates were synthesized as potential statine analogues and the stability of their possible tautomers was assessed using NMR, X-ray crystallography and ab initio calculations. The results establish that the cis-enol tautomeric form is the most stable one both in solution (CDCl3) and in the solid phase. In full agreement with the experimental data, the theoretical calculations predicted that the cis-enol tautomer would be the minimum energy tautomer. |
en |
heal.journalName |
European Journal of Organic Chemistry |
en |
dc.identifier.doi |
10.1002/1099-0690(200111)2001:22<4337::AID-EJOC4337>3.0.CO;2-S |
en |
dc.identifier.issue |
22 |
en |
dc.identifier.spage |
4337 |
en |
dc.identifier.epage |
4342 |
en |